A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study

ConclusionsThis observational study provides new data to the current literature in support of PR-FAM ’s positive effects in cognition, fatigue, depression, and QoL in a large, heterogeneous group of Greek MS patients in the real-world setting.Trial RegistrationClinicalTrials.gov identifier, NCT03164018.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research